Association of the Pro12Ala and C1431T variants of PPARγ and their haplotypes with susceptibility to gestational diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 10, 2011, Pages

  Heude, Barbara ^a,b   Pelloux, Veronique ^a,c,d   Forhan, Anne ^a,b   Bedel, Jean François ^a,d   Lacorte, Jean Marc ^c,d   Clément, Karine ^a,c,d   Charles, Marie Aline ^a,b   De Agostini, M ^e   Ducimetiere P ^e   Kaminski, M ^e   Saurel Cubizolles, M J ^e   Dargent, P ^e   Fritel, X ^e   Larroque, B ^e   Lelong, N ^e   Marchand, L ^e   Nabet, C ^e   Annesi Maesano, I ^e   Slama, R ^e   Goua, V ^e   Magnin, G ^e   Hankard, R ^e   Thiebaugeorges, O ^e   Schweitzer, M ^e   Foliguet, B ^e   Job Spira, N ^e   more..

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Nutrition and Endocrinology Department ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE TOLERANCE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PPARGAMMA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BODY MASS INDEX; COHORT STUDIES; DIABETES, GESTATIONAL; DNA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PREGNANCY;

EID: 80053557014     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0381     Document Type: Article

References (22)

1. Fajas L, Debril MB, Auwerx J 2001 PPARγ: an essential role in metabolic control. Nutr Metab Cardiovasc Dis 11:64-69 (Pubitemid 33687794)
2. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J 1998 A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287 (Pubitemid 28507675)
3. Doney AS, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH, Morris AD, Palmer CN 2004 Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47:555-558 (Pubitemid 38491254)
4. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P 1998 A genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans. Hum Mol Genet 7:435-440 (Pubitemid 28120633)
5. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES 2000 The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
6. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN 2003 Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182 (Pubitemid 36177070)
7. Tönjes A, Scholz M, Loeffler M, Stumvoll M 2006 Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor γ with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 29:2489-2497 (Pubitemid 44912258)
8. Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ, Andres R, Roth J, Shuldiner AR 1998 Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1808 (Pubitemid 28476259)
9. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P 2000 Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 24:195-199 (Pubitemid 30107568)
10. Ek J, Urhammer SA, Sørensen TI, Andersen T, Auwerx J, Pedersen O 1999 Homozygosity of the Pro12Ala variant of the peroxisome proliferation- activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892-895 (Pubitemid 29325082)
11. Chao TH, Li YH, Chen JH, Wu HL, Shi GY, Liu PY, Tsai WC, Guo HR 2004 The 161TT genotype in the exon 6 of the peroxisome-proliferator-activated receptor γ gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers. Clin Sci (Lond) 107:461-466
12. Wang XL, Oosterhof J, Duarte N 1999 Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease. Cardiovasc Res 44:588-594 (Pubitemid 30012062)
13. Valve R, Sivenius K, Miettinen R, Pihlajamäki J, Rissanen A, Deeb SS, Auwerx J, Uusitupa M, Laakso M 1999 Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 84:3708-3712 (Pubitemid 30645229)
14. Doney A, Fischer B, Frew D, Cumming A, Flavell DM, World M, Montgomery HE, Boyle D, Morris A, Palmer CN 2002 Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 3:21
15. Jaziri R, Lobbens S, Aubert R, Péan F, Lahmidi S, Vaxillaire M, Porchay I, Bellili N, Tichet J, Balkau B, Froguel P, Marre M, Fumeron F 2006 The PPARG Pro 12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 55:1157-1162 (Pubitemid 44100195)
16. Metzger BE, Coustan DR 1998 Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161-B167 (Pubitemid 28357050)
17. Kim C, Newton KM, Knopp RH 2002 Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862-1868
18. Watanabe RM 2011 Inherited destiny? Genetics and gestational diabetes mellitus. Genome Med 3:18
19. Drouillet P, Forhan A, De Lauzon-Guillain B, Thiébaugeorges O, Goua V, Magnin G, Schweitzer M, Kaminski M, Ducimetière P, Charles MA 2009 Maternal fatty acid intake and fetal growth: evidence for an association in overweight women. The 'EDEN mother-child'cohort (study of pre- and early postnatal determinants of the child's development and health). Br J Nutr 101:583-591
20. Tregouet DA, Garelle V 2007 A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 23:1038-1039 (Pubitemid 47050595)
21. Lauenborg J, Grarup N, Damm P, Borch-Johnsen K, Jørgensen T, Pedersen O, Hansen T 2009 Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 94:145-150
22. Pappa KI, Gazouli M, Economou K, Daskalakis G, Anastasiou E, Anagnou NP, Antsaklis A 2011 Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol 27:267-272